Platelet inhibitory effects of the nitric oxide donor drug MAHMA NONOate in vivo in rats

European Journal of Pharmacology

Volumn 482, Issue 1-3, 2003, Pages 265-270

  Homer, Kerry L ^a   Wanstall, Janet C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

In vivo; MAHMA NONOate; Nitric oxide (NO) donors; Platelet inhibition; S nitrosoglutathione; Vasodepression systemic

Indexed keywords

1 [N METHYL N [6 (N METHYLAMMONIOHEXYL)AMINO]]DIAZEN 1 IUM 1,2 DIOLATE; ADENOSINE DIPHOSPHATE; HYPERTENSIVE FACTOR; NITRIC OXIDE; NITRIC OXIDE DONOR; S NITROSOGLUTATHIONE; UNCLASSIFIED DRUG;

ANESTHESIA; ARTERIAL PRESSURE; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; LOW DRUG DOSE; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION; THROMBOCYTE KINETICS;

EID: 0344305471     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.10.016     Document Type: Article

References (21)

1. Aarts P.A., van den Broek S.A., Prins G.W., Kuiken G.D., Sixma J.J., Heethaar R.M. Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. Arteriosclerosis. 8:1988;819-824.
2. Crane M.S., Ollosson R., Moore K.P., Rossi A.G., Megson I.L. Novel role for low molecular weight plasma thiols in nitric oxide-mediated control of platelet function. J. Biol. Chem. 277:2002;46858-46863.
3. De Belder A.J., MacAllister R., Radomski M.W., Moncada S., Vallance P.J. Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc. Res. 28:1994;691-694.
4. Espey M.G., Miranda K.M., Thomas D.D., Wink D.A. Distinction between nitrosating mechanisms within human cells and aqueous solution. J. Biol. Chem. 276:2001;30085-30091.
5. Feelisch M., Stamler J.S. Donors of nitrogen oxides. Feelisch M., Stamler J.S. Methods in Nitric Oxide Research. 1996;71-115 Wiley, Chichester.
6. Homer K.L., Wanstall J.C. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate. Br. J. Pharmacol. 137:2002;1071-1081.
7. McMahon T.J., Moon R.E., Luschinger B.P., Carraway M.S., Stone A.E., Stolp B.W., Gow A.J., Pawloski J.R., Watke P., Singel D.J., Piantadosi C.A., Stamler J.S. Nitric oxide in the human respiratory cycle. Nat. Med. 8:2002;711-717.
8. Megson I.L., Sogo N., Mazzei F.A., Butler A.R., Walton J.C., Webb D.J. Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy. Br. J. Pharmacol. 131:2000;1391-1398.
9. Mehta J., Mehta P. Comparative effects of nitroprusside and nitroglycerin on platelet aggregation in patients with heart failure. J. Cardiovasc. Pharmacol. 2:1980;25-33.
10. Pawloski J.R., Swaminathan R.V., Stamler J.S. Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation. Circulation. 97:1998;263-267.
11. Picunio S., Simioni M., Doni M.G. Platelet activation and modulation of the induction of nitric oxide synthase in the conscious rat. Life Sci. 65:1999;1463-1475.
12. Radomski M.W., Rees D.D., Dutra A., Moncada S. S-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br. J. Pharmacol. 107:1992;745-749.
13. Ramsay B., Radomski M., de Belder A., Martin J.F., Lopez-Jaramillo P. Systemic effects of S-nitroso-glutathione in the human following intravenous infusion. Br. J. Clin. Pharmacol. 40:1995;101-102.
14. Rassaf T., Bryan N.S., Maloney R.E., Specian V., Kelm M., Kalyanaraman B., Rodriguez J., Feelisch M. NO adducts in mammalian red blood cells: too much or too little? Nat. Med. 9:2003;481-482.
15. Raulli R. Inhibition of human platelet aggregation by diazeniumdiolates: extent of inhibition correlates with nitric oxide load delivered. J. Pharm. Pharmacol. 50:1998;75-82.
16. Salas E., Langford E.J., Marrinan M.T., Martin J.F., Moncada S., de Belder A.J. S-nitrosogluthione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo. Heart. 80:1998;146-150.
17. Simon D.I., Stamler J.S., Jaraki O., Keaney J.F., Osborne J.A., Francis S.A., Singel D.J., Loscalzo J. Antiplatelet properties of protein S-nitrosothiols gluthione derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler. Thromb. 13:1993;791-799.
18. Sogo N., Magid K.S., Shaw C.A., Webb D.J., Megson I.L. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms. Biochem. Biophys. Res. Commun. 279:2000;412-419.
19. Stamler J.S., Jaraki O., Osborne J., Simon D.I., Keaney J., Vita J., Singel D., Valeri C.R., Loscalzo J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. U. S. A. 89:1992;7674-7677.
20. Tsikas D., Sandmann J., Gutzki F.M., Stichtenoth D.O., Frolich J.C. Measurement of S-nitrosoalbumin by gas chromatography-mass spectrometry: II. Quantitative determination of S-nitrosoalbumin in human plasma using S-[15N]nitrosoalbumin as internal standard. J. Chromatogr., B, Biomed. Sci. Appl. 726:1999;l13-l24.
21. Tsikas D., Sandmann J., Luessen P., Savva A., Rossa S., Stichtenoth D.O., Frolich J.C. S-transnitrosylation of albumin in human plasma and blood in vitro and in vivo in the rat. Biochim. Biophys. Acta. 1546:2001;422-434.